{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:53:43Z","timestamp":1768092823759,"version":"3.49.0"},"reference-count":147,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Despite dramatic improvement in kidney transplantation outcomes over the last decades due to advent of modern immunosuppressive agents, long-term outcomes remain poor. Antibody-mediated rejection (ABMR), a B cell driven process, accounts for the majority of chronic graft failures. There are currently no FDA-approved regimens for ABMR; however, several clinical trials are currently on-going. In this review, we present current mechanisms of B cell response in kidney transplantation, the clinical impact of sensitization and ABMR, the B cell response under current immunosuppressive regimens, and ongoing clinical trials for ABMR and desensitization treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2022.903068","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T06:27:25Z","timestamp":1654756045000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Harnessing the B Cell Response in Kidney Transplantation \u2013 Current State and Future Directions"],"prefix":"10.3389","volume":"13","author":[{"given":"Imran J.","family":"Anwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel F.","family":"DeLaura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qimeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Ladowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette M.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Kwun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart J.","family":"Knechtle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the Positive Crossmatch Test in Kidney Transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.4739.1049","article-title":"Effect of Locally Applied Cortisone Acetate on Survival of Skin Homografts in Rabbits","volume":"2","author":"Billingham","year":"1951","journal-title":"Br Med J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2217\/imt.11.2","article-title":"Immune Recognition and Rejection of Allogeneic Skin Grafts","volume":"3","author":"Benichou","year":"2011","journal-title":"Immunotherapy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/ajt.16502","article-title":"OPTN\/SRTR 2019 Annual Data Report: Kidney","author":"Hart","year":"2021","journal-title":"Am J Transplant"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2014530","article-title":"Long-Term Survival After Kidney Transplantation","volume":"385","author":"Hariharan","year":"2021","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014060588","article-title":"Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients","volume":"26","author":"Halloran","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181b96646","article-title":"Overcoming Chronic Rejection-Can it B","volume":"88","author":"Kwun","year":"2009","journal-title":"Transplantation"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03554.x","article-title":"Targeting B Cells and Antibody in Transplantation","volume":"11","author":"Clatworthy","year":"2011","journal-title":"Am J Transplant"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nri3802","article-title":"Memory B Cells","volume":"15","author":"Kurosaki","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404683","article-title":"Mechanisms of Action of Antithymocyte Globulin: T-Cell Depletion and Beyond","volume":"21","author":"Mohty","year":"2007","journal-title":"Leukemia"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000164159.20075.16","article-title":"Polyclonal Rabbit Antithymocyte Globulin Triggers B-Cell and Plasma Cell Apoptosis by Multiple Pathways","volume":"79","author":"Zand","year":"2005","journal-title":"Transplantation"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03210.x","article-title":"Immune Reconstitution Following Rabbit Antithymocyte Globulin","volume":"10","author":"Gurkan","year":"2010","journal-title":"Am J Transplant"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2046","article-title":"Low-Dose Anti-Thymocyte Globulin Inhibits Human B-Cell Differentiation Into Antibody-Secreting Cells","volume":"95","author":"Klaus","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03891.x","article-title":"An Analysis of Lymphocyte Phenotype After Steroid Avoidance With Either Alemtuzumab or Basiliximab Induction in Renal Transplantation","volume":"12","author":"Cherukuri","year":"2012","journal-title":"Am J Transplant"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04012.x","article-title":"B Cell Repopulation After Alemtuzumab Induction-Transient Increase in Transitional B Cells and Long-Term Dominance of Naive B Cells","volume":"12","author":"Heidt","year":"2012","journal-title":"Am J Transplant"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203261","article-title":"In Kidney Transplant Patients, Alemtuzumab But Not Basiliximab\/Low-Dose Rabbit Anti-Thymocyte Globulin Induces B Cell Depletion and Regeneration, Which Associates With a High Incidence of De Novo Donor-Specific Anti-HLA Antibody Development","volume":"191","author":"Todeschini","year":"2013","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2165\/11203990-000000000-00000","article-title":"Basiliximab: A Review of its Use as Induction Therapy in Renal Transplantation","volume":"24","author":"Mckeage","year":"2010","journal-title":"BioDrugs"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200301","article-title":"IL-2 Requirement for Human Plasma Cell Generation: Coupling Differentiation and Proliferation by Enhancing MAPK-ERK Signaling","volume":"189","author":"Le Gallou","year":"2012","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224203","article-title":"Single Fixed Low-Dose Rituximab as Induction Therapy Suppresses De Novo Donor-Specific Anti-HLA Antibody Production in ABO Compatible Living Kidney Transplant Recipients","volume":"14","author":"Tomita","year":"2019","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01497.x","article-title":"Pharmacodynamics of Rituximab in Kidney Allotransplantation","volume":"6","author":"Genberg","year":"2006","journal-title":"Am J Transplant"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112658","article-title":"Longitudinal Analysis of T and B Cell Phenotype and Function in Renal Transplant Recipients With or Without Rituximab Induction Therapy","volume":"9","author":"Kamburova","year":"2014","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031465","article-title":"Calcineurin Inhibitors Suppress Cytokine Production From Memory T Cells and Differentiation of Naive T Cells Into Cytokine-Producing Mature T Cells","volume":"7","author":"Tsuda","year":"2012","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01184","article-title":"The Calcineurin Inhibitor Tacrolimus Specifically Suppresses Human T Follicular Helper Cells","volume":"9","author":"Wallin","year":"2018","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2019.08.039","article-title":"Inhibition of T Helper Cell Differentiation by Tacrolimus or Sirolimus Results in Reduced B-Cell Activation: Effects on T Follicular Helper Cells","volume":"51","author":"Kraaijeveld","year":"2019","journal-title":"Transplant Proc"},{"key":"B26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2249.2009.04051.x","article-title":"Calcineurin Inhibitors Affect B Cell Antibody Responses Indirectly by Interfering With T Cell Help","volume":"159","author":"Heidt","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.657894","article-title":"Disruption of Tfh:B Cell Interactions Prevents Antibody-Mediated Rejection in a Kidney Transplant Model in Rats: Impact of Calcineurin Inhibitor Dose","volume":"12","author":"Steines","year":"2021","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003319","article-title":"Mycophenolic Acid Differentially Impacts B Cell Function Depending on the Stage of Differentiation","volume":"187","author":"Karnell","year":"2011","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01744","article-title":"Glucocorticoids-All-Rounders Tackling the Versatile Players of the Immune System","volume":"10","author":"Strehl","year":"2019","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00464-0","article-title":"Glucocorticoids in T Cell Development, Differentiation and Function","volume":"21","author":"Taves","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181874a36","article-title":"Effects of Immunosuppressive Drugs on Purified Human B Cells: Evidence Supporting the Use of MMF and Rapamycin","volume":"86","author":"Heidt","year":"2008","journal-title":"Transplantation"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705628","article-title":"Rapamycin, Not Cyclosporine, Permits Thymic Generation and Peripheral Preservation of CD4+ CD25+ FoxP3+ T Cells","volume":"39","author":"Coenen","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory Functions of mTOR Inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2019.11.017","article-title":"T Follicular Helper and Memory Cell Responses and the mTOR Pathway in Murine Heart Transplantation","volume":"39","author":"Xie","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01653-16","article-title":"mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses","volume":"91","author":"Ye","year":"2017","journal-title":"J Virol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/eji.201948241","article-title":"High-Throughput Compound Screen Reveals mTOR Inhibitors as Potential Therapeutics to Reduce (Auto)Antibody Production by Human Plasma Cells","volume":"50","author":"Tuijnenburg","year":"2020","journal-title":"Eur J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129658","article-title":"Differential Effects of Tacrolimus Versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells","volume":"10","author":"Traitanon","year":"2015","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00749.x","article-title":"Rational Development of LEA29Y (Belatacept), a High-Affinity Variant of CTLA4-Ig With Potent Immunosuppressive Properties","volume":"5","author":"Larsen","year":"2005","journal-title":"Am J Transplant"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017060679","article-title":"Control of Humoral Response in Renal Transplantation by Belatacept Depends on a Direct Effect on B Cells and Impaired T Follicular Helper-B Cell Crosstalk","volume":"29","author":"Leibler","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ajt.12526","article-title":"Costimulation Blockade Alters Germinal Center Responses and Prevents Antibody-Mediated Rejection","volume":"14","author":"Kim","year":"2014","journal-title":"Am J Transplant"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12350","article-title":"Reversing Endogenous Alloreactive B Cell GC Responses With Anti-CD154 or CTLA-4ig","volume":"13","author":"Chen","year":"2013","journal-title":"Am J Transplant"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13761","article-title":"Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection","volume":"16","author":"Young","year":"2016","journal-title":"Am J Transplant"},{"key":"B43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri2217","article-title":"Germinal Centres: Role in B-Cell Physiology and Malignancy","volume":"8","author":"Klein","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00686","article-title":"B Cell Immunity in Solid Organ Transplantation","volume":"7","author":"Karahan","year":"2017","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.03.016","article-title":"B Cell Responses: Cell Interaction Dynamics and Decisions","volume":"177","author":"Cyster","year":"2019","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/44076","article-title":"Commitment to the B-Lymphoid Lineage Depends on the Transcription Factor Pax5","volume":"401","author":"Nutt","year":"1999","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-021089","article-title":"Naive Recirculating B Cells Mature Simultaneously in the Spleen and Bone Marrow","volume":"109","author":"Cariappa","year":"2007","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055649","article-title":"Chemokines and Chemokine Receptors in Lymphoid Tissue Dynamics","volume":"34","author":"Schulz","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00389-8","article-title":"Blood Dendritic Cells Interact With Splenic Marginal Zone B Cells to Initiate T-Independent Immune Responses","volume":"17","author":"Balazs","year":"2002","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00065","article-title":"Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage","volume":"5","author":"Moens","year":"2014","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1126\/science.1176676","article-title":"Bcl6 Mediates the Development of T Follicular Helper Cells","volume":"325","author":"Nurieva","year":"2009","journal-title":"Science"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.02.012","article-title":"Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell Differentiation","volume":"36","author":"Ballesteros-Tato","year":"2012","journal-title":"Immunity"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nri3795","article-title":"The Generation of Antibody-Secreting Plasma Cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nature07345","article-title":"SAP-Controlled T-B Cell Interactions Underlie Germinal Centre Formation","volume":"455","author":"Qi","year":"2008","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.01.010","article-title":"Optimal Germinal Center Responses Require a Multistage T Cell:B Cell Adhesion Process Involving Integrins, SLAM-Associated Protein, and CD84","volume":"32","author":"Cannons","year":"2010","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14142","article-title":"Renal Operational Tolerance Is Associated With a Defect of Blood Tfh Cells That Exhibit Impaired B Cell Help","volume":"17","author":"Chenouard","year":"2017","journal-title":"Am J Transplant"},{"key":"B57","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/ajt.14987","article-title":"Longitudinal Profile of Circulating T Follicular Helper Lymphocytes Parallels Anti-HLA Sensitization in Renal Transplant Recipients","volume":"19","author":"Cano-Romero","year":"2019","journal-title":"Am J Transplant"},{"key":"B58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/ajt.15517","article-title":"Circulating T Follicular Helper Cells are a Biomarker of Humoral Alloreactivity and Predict Donor-Specific Antibody Formation After Transplantation","volume":"20","author":"La Muraglia","year":"2020","journal-title":"Am J Transplant"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020030320","article-title":"Coordinated Circulating T Follicular Helper and Activated B Cell Responses Underlie the Onset of Antibody-Mediated Rejection in Kidney Transplantation","volume":"31","author":"Louis","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1126\/science.1077002","article-title":"A Critical Role for IL-21 in Regulating Immunoglobulin Production","volume":"298","author":"Ozaki","year":"2002","journal-title":"Science"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.12.7867","article-title":"IL-21 Induces Differentiation of Human Naive and Memory B Cells Into Antibody-Secreting Plasma Cells","volume":"175","author":"Ettinger","year":"2005","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2871","article-title":"Critical Role for Stat3 in T-Dependent Terminal Differentiation of IgG B Cells","volume":"107","author":"Fornek","year":"2006","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00721","article-title":"The Maintenance of Memory Plasma Cells","volume":"10","author":"Khodadadi","year":"2019","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/tri.13484","article-title":"Caveats of HLA Antibody Detection by Solid-Phase Assays","volume":"33","author":"Wehmeier","year":"2020","journal-title":"Transpl Int"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1802677","article-title":"Antibody-Mediated Rejection of Solid-Organ Allografts","volume":"379","author":"Loupy","year":"2018","journal-title":"New Engl J Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report","volume":"18","author":"Tambur","year":"2018","journal-title":"Am J Transplant"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft362","article-title":"Sensitization From Transfusion in Patients Awaiting Primary Kidney Transplant","volume":"28","author":"Yabu","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw099","article-title":"The Mode of Sensitization and its Influence on Allograft Outcomes in Highly Sensitized Kidney Transplant Recipients","volume":"31","author":"Redfield","year":"2016","journal-title":"Nephrol Dialysis Transplant"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12048","article-title":"Frequency and Determinants of Pregnancy-Induced Child-Specific Sensitization","volume":"13","author":"Honger","year":"2013","journal-title":"Am J Transplant"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.205","article-title":"Preformed Circulating HLA-Specific Memory B Cells Predict High Risk of Humoral Rejection in Kidney Transplantation","volume":"88","author":"Lucia","year":"2015","journal-title":"Kidney Int"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002516","article-title":"An Easy and Sensitive Method to Profile the Antibody Specificities of HLA-Specific Memory B Cells","volume":"103","author":"Karahan","year":"2019","journal-title":"Transplantation"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2015.01.014","article-title":"Quantification of HLA Class II-Specific Memory B Cells in HLA-Sensitized Individuals","volume":"76","author":"Karahan","year":"2015","journal-title":"Hum Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14922","article-title":"Measuring and Monitoring Equity in Access to Deceased Donor Kidney Transplantation","volume":"18","author":"Stewart","year":"2018","journal-title":"Am J Transplant"},{"key":"B74","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.humimm.2016.11.004","article-title":"Casting a Smaller Net Into a Bigger Donor Pool: A Single Center's Experience With the New Kidney Allocation System","volume":"78","author":"Houp","year":"2017","journal-title":"Hum Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13751","article-title":"Managing Highly Sensitized Renal Transplant Candidates in the Era of Kidney Paired Donation and the New Kidney Allocation System: Is There Still a Role for Desensitization","volume":"33","author":"Schinstock","year":"2019","journal-title":"Clin Transplant"},{"key":"B76","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.kint.2017.07.018","article-title":"Kidney Allocation Based on Proven Acceptable Antigens Results in Superior Graft Survival in Highly Sensitized Patients","volume":"93","author":"Heidt","year":"2018","journal-title":"Kidney Int"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15486","article-title":"Allocation to Highly Sensitized Patients Based on Acceptable Mismatches Results in Low Rejection Rates Comparable to Nonsensitized Patients","volume":"19","author":"Heidt","year":"2019","journal-title":"Am J Transplant"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-Mediated Rejection Criteria - an Addition to the Banff 97 Classification of Renal Allograft Rejection","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14320","article-title":"Incidence, Risk Factors, Treatment, and Consequences of Antibody-Mediated Kidney Transplant Rejection: A Systematic Review","volume":"35","author":"Hart","year":"2021","journal-title":"Clin Transplant"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02524.x","article-title":"Positive Cross-Match Living Donor Kidney Transplantation: Longer-Term Outcomes","volume":"9","author":"Haririan","year":"2009","journal-title":"Am J Transplant"},{"key":"B81","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting Report: Revised Diagnostic Criteria for Chronic Active T Cell-Mediated Rejection, Antibody-Mediated Rejection, and Prospects for Integrative Endpoints for Next-Generation Clinical Trials","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 Kidney Meeting Report (I): Updates on and Clarification of Criteria for T Cell- and Antibody-Mediated Rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transplant"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021040433","article-title":"Donor-Specific Antibody Is Associated With Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified as No Rejection","volume":"32","author":"Madill-Thomsen","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-Mediated Rejection Due to Preexisting Versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients","volume":"28","author":"Aubert","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15074","article-title":"Histological Picture of Antibody-Mediated Rejection Without Donor-Specific Anti-HLA Antibodies: Clinical Presentation and Implications for Outcome","volume":"19","author":"Senev","year":"2019","journal-title":"Am J Transplant"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020030306","article-title":"Transcriptional Changes in Kidney Allografts With Histology of Antibody-Mediated Rejection Without Anti-HLA Donor-Specific Antibodies","volume":"31","author":"Callemeyn","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V9112129","article-title":"Beneficial Effects of Treatment of Early Subclinical Rejection: A Randomized Study","volume":"9","author":"Rush","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014040399","article-title":"Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts","volume":"26","author":"Loupy","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/MOT.0000000000000941","article-title":"Emerging Biomarkers in Kidney Transplantation and Challenge of Clinical Implementation","volume":"27","author":"Westphal","year":"2022","journal-title":"Curr Opin Organ Transplant"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1046\/j.1523-1755.2001.00030.x","article-title":"International Variation in the Interpretation of Renal Transplant Biopsies: Report of the CERTPAP Project","volume":"60","author":"Furness","year":"2001","journal-title":"Kidney Int"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-020-0321-6","article-title":"Digital Pathology and Computational Image Analysis in Nephropathology","volume":"16","author":"Barisoni","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa181","article-title":"Artificial Intelligence: Is There a Potential Role in Nephropathology","volume":"37","author":"Hermsen","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15850","article-title":"Banff Digital Pathology Working Group: Going Digital in Transplant Pathology","volume":"20","author":"Farris","year":"2020","journal-title":"Am J Transplant"},{"key":"B95","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1600-6143.2011.03525.x","article-title":"Summary of FDA Antibody-Mediated Rejection Workshop","volume":"11","author":"Archdeacon","year":"2011","journal-title":"Am J Transplant"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002049","article-title":"The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis","volume":"102","author":"Wan","year":"2018","journal-title":"Transplantation"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003095","article-title":"Recommended Treatment for Antibody-Mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group","volume":"104","author":"Schinstock","year":"2020","journal-title":"Transplantation"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.651222","article-title":"Therapies for Chronic Allograft Rejection","volume":"12","author":"Kim","year":"2021","journal-title":"Front Pharmacol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.3390\/jcm10163656","article-title":"Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient","volume":"10","author":"Olaso","year":"2021","journal-title":"J Clin Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004107","article-title":"Shifting Clinical Trial Endpoints in Kidney Transplantation: The Rise of Composite Endpoints and Machine Learning to Refine Prognostication","author":"Anwar","year":"2022","journal-title":"Transplantation"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13884","article-title":"Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-IL2 Receptor Monoclonal Antibodies","volume":"17","author":"Hellemans","year":"2017","journal-title":"Am J Transplant"},{"key":"B102","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients","year":"2009","journal-title":"Am J Transplant"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.766698","article-title":"The Multifaceted Roles of B Cells in the Thymus: From Immune Tolerance to Autoimmunity","volume":"12","author":"Castaneda","year":"2021","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2010.04.004","article-title":"Preferential Increase in Memory and Regulatory Subsets During T-Lymphocyte Immune Reconstitution After Thymoglobulin Induction Therapy With Maintenance Sirolimus vs Cyclosporine","volume":"23","author":"Morelon","year":"2010","journal-title":"Transpl Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2012.02.003","article-title":"The Effect of Low and Ultra-Low Dosages Thymoglobulin on Peripheral T, B and NK Cells in Kidney Transplant Recipients","volume":"26","author":"Kho","year":"2012","journal-title":"Transpl Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12751","article-title":"Dynamic Changes of B-Cell Compartments in Kidney Transplantation: Lack of Transitional B Cells is Associated With Allograft Rejection","volume":"29","author":"Svachova","year":"2016","journal-title":"Transpl Int"},{"key":"B107","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/diagnostics11040641","article-title":"Monitoring of B Cell in Kidney Transplantation: Development of a Novel Clusters Analysis and Role of Transitional B Cells in Transplant Outcome","volume":"11","author":"Alfaro","year":"2021","journal-title":"Diagn (Basel)"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12220","article-title":"A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs But Alters Phenotype and Function","volume":"13","author":"Kamburova","year":"2013","journal-title":"Am J Transplant"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory Action of Glucocorticoids\u2013New Mechanisms for Old Drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/ni1413","article-title":"The Kinases Aurora B and mTOR Regulate the G1-S Cell Cycle Progression of T Lymphocytes","volume":"8","author":"Song","year":"2007","journal-title":"Nat Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2002.01110.x","article-title":"Cyclosporin-A Differentially Affects Apoptosis During In Vivo Rat Thymocyte Maturation","volume":"56","author":"Damoiseaux","year":"2002","journal-title":"Scand J Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1603","article-title":"Phosphatidylinositol-3-OH Kinase and Nutrient-Sensing mTOR Pathways Control T Lymphocyte Trafficking","volume":"9","author":"Sinclair","year":"2008","journal-title":"Nat Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-287821","article-title":"Constitutive Reductions in mTOR Alter Cell Size, Immune Cell Development, and Antibody Production","volume":"117","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500940","article-title":"Cutting Edge: CTLA-4ig Inhibits Memory B Cell Responses and Promotes Allograft Survival in Sensitized Recipients","volume":"195","author":"Chen","year":"2015","journal-title":"J Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants From Extended Criteria Donors (BENEFIT-EXT Study)","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transplant"},{"key":"B117","doi-asserted-by":"publisher","first-page":"CD010699","DOI":"10.1002\/14651858.CD010699.pub2","article-title":"Belatacept for Kidney Transplant Recipients","author":"Masson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12712","article-title":"Renal Transplantation Using Belatacept Without Maintenance Steroids or Calcineurin Inhibitors","volume":"14","author":"Kirk","year":"2014","journal-title":"Am J Transplant"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14721","article-title":"De Novo Donor-Specific Antibodies in Belatacept-Treated vs Cyclosporine-Treated Kidney-Transplant Recipients: Post Hoc Analyses of the Randomized Phase III BENEFIT and BENEFIT-EXT Studies","volume":"18","author":"Bray","year":"2018","journal-title":"Am J Transplant"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.16.8789","article-title":"CTLA4-Ig and Anti-CD40 Ligand Prevent Renal Allograft Rejection in Primates","volume":"94","author":"Kirk","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/9536","article-title":"Treatment With Humanized Monoclonal Antibody Against CD154 Prevents Acute Renal Allograft Rejection in Nonhuman Primates","volume":"5","author":"Kirk","year":"1999","journal-title":"Nat Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/72162","article-title":"Thromboembolic Complications After Treatment With Monoclonal Antibody Against CD40 Ligand","volume":"6","author":"Kawai","year":"2000","journal-title":"Nat Med"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/art.10856","article-title":"A Short Course of BG9588 (Anti-CD40 Ligand Antibody) Improves Serologic Activity and Decreases Hematuria in Patients With Proliferative Lupus Glomerulonephritis","volume":"48","author":"Boumpas","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000110291.29370.C0","article-title":"Thrombophilia Associated With Anti-CD154 Monoclonal Antibody Treatment and its Prophylaxis in Nonhuman Primates","volume":"77","author":"Koyama","year":"2004","journal-title":"Transplantation"},{"key":"B125","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/MOT.0000000000000656","article-title":"The Past, Present, and Future of Costimulation Blockade in Organ Transplantation","volume":"24","author":"Schroder","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"key":"B126","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40-CD40 Ligand","volume":"67","author":"Van Kooten","year":"2000","journal-title":"J Leukoc Biol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000286058.79448.c7","article-title":"A Novel Fully Human Anti-CD40 Monoclonal Antibody, 4D11, for Kidney Transplantation in Cynomolgus Monkeys","volume":"84","author":"Imai","year":"2007","journal-title":"Transplantation"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14872","article-title":"Characterization of the In Vitro and In Vivo Properties of CFZ533, a Blocking and non-Depleting Anti-CD40 Monoclonal Antibody","volume":"18","author":"Ristov","year":"2018","journal-title":"Am J Transplant"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13377","article-title":"A Novel, Blocking, Fc-Silent Anti-CD40 Monoclonal Antibody Prolongs Nonhuman Primate Renal Allograft Survival in the Absence of B Cell Depletion","volume":"15","author":"Cordoba","year":"2015","journal-title":"Am J Transplant"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and Long-Term Outcomes in Kidney Transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050085","article-title":"Costimulation Blockade With Belatacept in Renal Transplantation","volume":"353","author":"Vincenti","year":"2005","journal-title":"N Engl J Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A Phase III Study of Belatacept-Based Immunosuppression Regimens Versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05840710","article-title":"Switching From Calcineurin Inhibitor-Based Regimens to a Belatacept-Based Regimen in Renal Transplant Recipients: A Randomized Phase II Study","volume":"6","author":"Rostaing","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13613","article-title":"CD57+ CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection","volume":"16","author":"Espinosa","year":"2016","journal-title":"Am J Transplant"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000736","article-title":"Functional Characteristics and Phenotypic Plasticity of CD57 + PD1 \u2013 CD4 T Cells and Their Relationship With Transplant Immunosuppression","volume":"206","author":"Shaw","year":"2021","journal-title":"J Immunol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14350","article-title":"Increased Pretransplant Frequency of CD28(+) CD4(+) TEM Predicts Belatacept-Resistant Rejection in Human Renal Transplant Recipients","volume":"17","author":"Cortes-Cerisuelo","year":"2017","journal-title":"Am J Transplant"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14349","article-title":"Belatacept-Resistant Rejection Is Associated With CD28(+) Memory CD8 T Cells","volume":"17","author":"Mathews","year":"2017","journal-title":"Am J Transplant"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16386","article-title":"Optimization of De Novo Belatacept-Based Immunosuppression Administered to Renal Transplant Recipients","volume":"21","author":"Kirk","year":"2021","journal-title":"Am J Transplant"},{"key":"B139","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/ajt.15859","article-title":"What Have We Learned About How to Prevent and Treat Antibody-Mediated Rejection in Kidney Transplantation","author":"Nickerson","year":"2020","journal-title":"Am J Transplant"},{"key":"B140","article-title":"Clazakizumab for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: Phase 3 IMAGINE Study Design","volume":"21","author":"Nickerson","year":"2021","journal-title":"Am J Transplant"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020071106","article-title":"A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection","volume":"32","author":"Doberer","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017010991","article-title":"Successful Desensitization With Proteasome Inhibition and Costimulation Blockade in Sensitized Nonhuman Primates","volume":"1","author":"Kwun","year":"2017","journal-title":"Blood Adv"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15067","article-title":"Dual Targeting: Combining Costimulation Blockade and Bortezomib to Permit Kidney Transplantation in Sensitized Recipients","volume":"19","author":"Burghuber","year":"2019","journal-title":"Am J Transplant"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019030304","article-title":"Pretransplant Desensitization With Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients","volume":"30","author":"Ezekian","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"l4923","DOI":"10.1136\/bmj.l4923","article-title":"Prediction System for Risk of Allograft Loss in Patients Receiving Kidney Transplants: International Derivation and Validation Study","volume":"366","author":"Loupy","year":"2019","journal-title":"BMJ"},{"key":"B146","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13063-022-06198-9","article-title":"Safety, Tolerability, and Efficacy of Monoclonal CD38 Antibody Felzartamab in Late Antibody-Mediated Renal Allograft Rejection: Study Protocol for a Phase 2 Trial","volume":"23","author":"Mayer","year":"2022","journal-title":"Trials"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003247","article-title":"CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-Mediated Kidney Allograft Rejection","volume":"105","author":"Doberer","year":"2021","journal-title":"Transplantation"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.903068\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T06:27:30Z","timestamp":1654756050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.903068\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":147,"alternative-id":["10.3389\/fimmu.2022.903068"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.903068","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"article-number":"903068"}}